In cancer patients who undergo surgery, legalizing medical marijuana with state-run dispensaries may lead to fewer prescriptions for strong opioids.

Providence Holy Cross Medical Center is the first Providence hospital in the San Fernando Valley to offer a minimally ...

Third quarter 2025 revenues increased 1% to $3.75 billion versus third quarter 2024Dupixent® global net sales (recorded by Sanofi) increased 27% to $4.86 billion EYLEA HD® U.S. net sales increased 10% ...

Cardiologists at NIMS, Hyderabad, successfully performed a rare Pulmonary Artery Denervation (PADN) procedure on a ...

Penumbra, Inc. announced the results of the landmark STORM-PE randomized controlled trial (RCT), which found that the use of mechanical thrombectomy, specifically computer assisted vacuum thrombectomy ...

Co., Ltd. ("Fosun Pharma" or "the Group"; SSE: 600196, HKEX: 02196), a leading innovation-driven global healthcare company, announced its financial results for the first three quarters ...

Adjuvant treatment with alectinib (Alecensa) yielded a 4-year overall survival (OS) rate of 98.4% in patients with resected, ALK mutation-positive, early stage non–small cell lung cancer (NSCLC), ...

Grape seed extract—a dietary supplement made from the seeds of wine grapes—has been investigated to see if it can help reduce ...

Q3 2025 Earnings Call Transcript October 21, 2025 Intuitive Surgical, Inc. beats earnings expectations. Reported EPS is $2.4, ...

CHICAGO -- A series of large, real-world analyses supported benefit of GLP-1 receptor agonists in cardiopulmonary indications for patients with type 2 diabetes, researchers reported at the CHEST ...

Results from the pivotal EV-303 trial demonstrated that, when used before and after surgery, the combination reduced the risk of recurrence, progression or death by 60% and the risk of death by 50% in ...

Comparable overall survival seen at seven and 10 years, lung cancer-specific survival, and recurrence-free survival.